
Joseph Schwartz
Stock Analyst at Leerink Partners
(4.97)
# 93
Out of 5,189 analysts
1286
Total ratings
53.2%
Success rate
31.5%
Average return
Main Sectors:
Stocks Rated by Joseph Schwartz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IRLA IRulya Therapeutics | Reiterated: Buy | $68 | $39.88 | +70.51% | 2 | Nov 19, 2026 | |
| ELOX Eloxx Pharmaceuticals | Reiterated: Buy | $32 | $10.69 | +199.35% | 2 | Nov 17, 2026 | |
| PHVS Pharvaris | Reiterated: Buy | $65 | $31.28 | +107.80% | 39 | Nov 16, 2026 | |
| QURE uniQure | Reiterated: Buy | $70 | $19.35 | +261.76% | 64 | Nov 16, 2026 | |
| ASND Ascendis Pharma | Reiterated: Buy | $305 → $326 | $252.73 | +28.99% | 73 | Nov 13, 2026 | |
| PEPG PepGen | Reiterated: Buy | $10 → $16 | $3.78 | +323.28% | 31 | Nov 10, 2026 | |
| MIRM Mirum Pharmaceuticals | Reiterated: Buy | $154 → $140 | $96.13 | +45.64% | 2 | Nov 5, 2026 | |
| RARE Ultragenyx Pharmaceutical | Reiterated: Buy | $33 | $16.48 | +100.24% | 72 | Nov 5, 2026 | |
| SLDB Solid Biosciences | Reiterated: Buy | $20 | $6.25 | +220.00% | 48 | Nov 5, 2026 | |
| WVE Wave Life Sciences | Rated: Buy | $25 → $10 | $2.56 | +290.63% | 32 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28.69 | $8.24 | +248.22% | 2 | Oct 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $39.91 | - | 51 | Sep 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $80 | $10.72 | +646.27% | 36 | Jul 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $24 → $4 | $3.69 | +8.40% | 37 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $60 → $62 | $60.41 | +2.63% | 90 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $1 → $9 | $5.08 | +77.17% | 23 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $25 | $6.92 | +261.27% | 1 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $160 → $120 | $38.00 | +215.79% | 32 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $31.37 | +59.39% | 9 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $15 | $13.33 | +12.53% | 107 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $47.00 | - | 87 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.04 | - | 50 | Dec 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $2 | $0.26 | +669.23% | 31 | Dec 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $12 → $16 | $14.70 | +8.84% | 52 | Dec 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $5 → $14 | $9.02 | +55.21% | 29 | Dec 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $115 | $69.00 | n/a | 1 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $54 | $56.42 | n/a | 33 | Oct 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $141.33 | n/a | 63 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $3.14 | n/a | 22 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 | $0.9602 | n/a | 29 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 | $2.70 | n/a | 19 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $14 | $314.32 | n/a | 1 | Sep 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $150 → $30 | $6.14 | n/a | 10 | Aug 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $40 → $34 | $26.58 | n/a | 3 | Feb 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $121.40 | n/a | 28 | Aug 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $435.64 | n/a | 1 | Aug 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $16.97 | n/a | 1 | Jul 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $31 → $4 | $46.53 | n/a | 16 | Apr 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $310.53 | n/a | 1 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $54.37 | $257.92 | n/a | 1 | Apr 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $5 → $30 | $0.287 | n/a | 2 | Jan 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $37 → $23 | $10.00 | n/a | 2 | Nov 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $12 | $1.04 | n/a | 5 | Sep 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $121 → $126 | $554.73 | n/a | 4 | Apr 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $9.02 | n/a | 11 | Nov 13, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $0.0708 | n/a | 5 | Nov 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $14 | $1.24 | n/a | 6 | Nov 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $0.7774 | n/a | 1 | Mar 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $664 | $920.69 | n/a | 7 | Oct 26, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $512 → $425 | $249.59 | n/a | 3 | Sep 15, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 → $8 | $50.78 | n/a | 3 | May 19, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $10.57 | n/a | 6 | Oct 30, 2013 |
IRulya Therapeutics
Nov 19, 2026
Reiterated: Buy
Price Target: $68
Current: $39.88
Upside: +70.51%
Eloxx Pharmaceuticals
Nov 17, 2026
Reiterated: Buy
Price Target: $32
Current: $10.69
Upside: +199.35%
Pharvaris
Nov 16, 2026
Reiterated: Buy
Price Target: $65
Current: $31.28
Upside: +107.80%
uniQure
Nov 16, 2026
Reiterated: Buy
Price Target: $70
Current: $19.35
Upside: +261.76%
Ascendis Pharma
Nov 13, 2026
Reiterated: Buy
Price Target: $305 → $326
Current: $252.73
Upside: +28.99%
PepGen
Nov 10, 2026
Reiterated: Buy
Price Target: $10 → $16
Current: $3.78
Upside: +323.28%
Mirum Pharmaceuticals
Nov 5, 2026
Reiterated: Buy
Price Target: $154 → $140
Current: $96.13
Upside: +45.64%
Ultragenyx Pharmaceutical
Nov 5, 2026
Reiterated: Buy
Price Target: $33
Current: $16.48
Upside: +100.24%
Solid Biosciences
Nov 5, 2026
Reiterated: Buy
Price Target: $20
Current: $6.25
Upside: +220.00%
Wave Life Sciences
Oct 29, 2026
Rated: Buy
Price Target: $25 → $10
Current: $2.56
Upside: +290.63%
Oct 1, 2026
Reiterated: Buy
Price Target: $28.69
Current: $8.24
Upside: +248.22%
Sep 23, 2026
Reiterated: Buy
Price Target: n/a
Current: $39.91
Upside: -
Jul 27, 2026
Upgraded: Buy
Price Target: $80
Current: $10.72
Upside: +646.27%
Jun 2, 2026
Downgraded: Hold
Price Target: $24 → $4
Current: $3.69
Upside: +8.40%
May 18, 2026
Reiterated: Hold
Price Target: $60 → $62
Current: $60.41
Upside: +2.63%
May 15, 2026
Upgraded: Buy
Price Target: $1 → $9
Current: $5.08
Upside: +77.17%
May 15, 2026
Initiated Coverage: Buy
Price Target: $25
Current: $6.92
Upside: +261.27%
May 15, 2026
Reiterated: Buy
Price Target: $160 → $120
Current: $38.00
Upside: +215.79%
Mar 25, 2026
Reiterated: Buy
Price Target: $50
Current: $31.37
Upside: +59.39%
Mar 25, 2026
Reiterated: Hold
Price Target: $15
Current: $13.33
Upside: +12.53%
Jan 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $47.00
Upside: -
Dec 31, 2025
Reiterated: Hold
Price Target: n/a
Current: $1.04
Upside: -
Dec 29, 2025
Reiterated: Buy
Price Target: $8 → $2
Current: $0.26
Upside: +669.23%
Dec 3, 2025
Downgraded: Hold
Price Target: $12 → $16
Current: $14.70
Upside: +8.84%
Dec 3, 2025
Upgraded: Buy
Price Target: $5 → $14
Current: $9.02
Upside: +55.21%
Nov 10, 2025
Initiated Coverage: Buy
Price Target: $115
Current: $69.00
Upside: n/a
Oct 16, 2025
Reiterated: Hold
Price Target: $54
Current: $56.42
Upside: n/a
Sep 29, 2025
Reiterated: Buy
Price Target: n/a
Current: $141.33
Upside: n/a
Aug 15, 2025
Reiterated: Buy
Price Target: $25
Current: $3.14
Upside: n/a
Aug 12, 2024
Reiterated: Hold
Price Target: $1
Current: $0.9602
Upside: n/a
May 7, 2024
Reiterated: Hold
Price Target: $10
Current: $2.70
Upside: n/a
Sep 7, 2023
Reiterated: Hold
Price Target: $14
Current: $314.32
Upside: n/a
Aug 18, 2023
Downgraded: Hold
Price Target: $150 → $30
Current: $6.14
Upside: n/a
Feb 3, 2023
Reiterated: Hold
Price Target: $40 → $34
Current: $26.58
Upside: n/a
Aug 5, 2022
Reiterated: Buy
Price Target: $30
Current: $121.40
Upside: n/a
Aug 4, 2022
Rated: Hold
Price Target: n/a
Current: $435.64
Upside: n/a
Jul 13, 2022
Reiterated: Buy
Price Target: n/a
Current: $16.97
Upside: n/a
Apr 5, 2022
Downgraded: Hold
Price Target: $31 → $4
Current: $46.53
Upside: n/a
May 7, 2021
Downgraded: Sell
Price Target: n/a
Current: $310.53
Upside: n/a
Apr 15, 2021
Reiterated: Buy
Price Target: $54.37
Current: $257.92
Upside: n/a
Jan 6, 2021
Downgraded: Hold
Price Target: $5 → $30
Current: $0.287
Upside: n/a
Nov 28, 2018
Initiated Coverage: Buy
Price Target: $37 → $23
Current: $10.00
Upside: n/a
Sep 26, 2017
Reiterated: Buy
Price Target: $10 → $12
Current: $1.04
Upside: n/a
Apr 3, 2017
Reiterated: Hold
Price Target: $121 → $126
Current: $554.73
Upside: n/a
Nov 13, 2016
Reiterated: Buy
Price Target: n/a
Current: $9.02
Upside: n/a
Nov 10, 2016
Reiterated: Buy
Price Target: $8
Current: $0.0708
Upside: n/a
Nov 10, 2016
Reiterated: Buy
Price Target: $12 → $14
Current: $1.24
Upside: n/a
Mar 8, 2016
Reiterated: Buy
Price Target: $24
Current: $0.7774
Upside: n/a
Oct 26, 2015
Reiterated: Buy
Price Target: $664
Current: $920.69
Upside: n/a
Sep 15, 2015
Reiterated: Buy
Price Target: $512 → $425
Current: $249.59
Upside: n/a
May 19, 2014
Initiated Coverage: Buy
Price Target: $20 → $8
Current: $50.78
Upside: n/a
Oct 30, 2013
Downgraded: Hold
Price Target: n/a
Current: $10.57
Upside: n/a